Abstract:Tuberous sclerosis (TSC) is a multisystem genetic disorder characterized by neurological lesions with hamartomas, [ 1 ] resulting from mutations in the tuberous sclerosis complex 1 (TSC1, MIM *605284, 9q34.13) or tuberous sclerosis complex 2 (TSC2, MIM *191092, 16p13.3) tumor suppressor genes, often with intellectual disability, epilepsy and autism. [ 2 , 3 ] It was first described in depth in Bernville in 1880, and it is now estimated that nearly 2 million people worldwide are affected by the disease. [ 4 ] TSC is inherited in an autosomal dominant fashion, and the clinical features vary widely between individuals, even in the same family. General children often have infantile cramps, white matter abnormalities, cysts, calcification, and subependendymal nodules, [ 5 ] most adults suffer from neuropsychiatric disorders and renal angiomyolipoma. [ 6 ] With the development of whole-exon sequencing technology, the pathogenic loci of TSC have been detected for many years, but for many people, the overall prognosis is very poor. TSC has been examined for many years with the development of whole-exon sequencing technology, but its ability is limited to screen a large range of the human genome in a single reaction.

Identification of a novel TSC1 variant in a family with developmental and epileptic encephalopathies: A case report and literature review